Changes in Patient-Reported Health Status in Advanced Cancer Patients from a Symptom Management Clinic: A Longitudinal Study Conducted in China

Table 3

Results from the GEE model.

Parameter estimates
Parameter	B	Std. Error	95% Wald confidence interval		Hypothesis test			Exp (B)	95% Wald confidence interval for Exp (B)
			Lower	Upper	Wald chi-square	df	Sig.		Lower	Upper
(Intercept)	1.127	0.0653	1.000	1.255	298.209	1	0.000	3.088	2.717	3.509
ECOG-PS	−0.094	0.0138	−0.121	−0.067	46.754	1	0.000	0.910	0.886	0.935
Pain	−0.016	0.0047	−0.025	−0.007	11.630	1	0.001	0.984	0.975	0.993
Walking	−0.028	0.0078	−0.044	−0.013	13.185	1	0.000	0.972	0.957	0.987
HADS	−0.009	0.0015	−0.012	−0.006	34.462	1	0.000	0.991	0.988	0.994
(Scale)	0.033

Dependent variable: EQ-5D-5L index score model: (Intercept), age range, disease duration range, sex, job, race, marital status, education, income, medical coverage, diagnosis, treatment, ECOG-PS, symptoms and interference (pain, fatigue, nausea, insomnia, distress, shortness of breath, memory, appetite, drowsy, dry mouth, sadness, vomiting, numbness, constipation, general activity, mood, work, relationship, walking, enjoyment), anxiety/depression from HADS, Time (baseline, T1-two week follow-up, T2-four week follow-up).